PHARMINDEX POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID5260019619

KRS0000129566

Share capital243,100.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. OLKUSKA 7, 02-604 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

PHARMINDEX POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. OLKUSKA 7, 02-604 WARSZAWA

Show on map

NIP

5260019619

REGON

010311790

KRS

0000129566

Legal form

limited liability company

Register Address

UL. OLKUSKA 7, 02-604 WARSZAWA

Date of registration in KRS

2002-09-10

Date of commencement of economic activity

2002-09-10

Act signature

WA.XIII NS-REJ.KRS/37691/22/422/ADE

Pkd codes

63.11.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services

58.11.Z - Publishing of books

58.12.Z - Publishing of newspapers

58.19.Z - Other publishing activities, excluding software publishing

62.01.Z - Activities related to programming, IT consulting, and related activities

62.03.Z - Activities related to programming, IT consulting, and related activities

62.09.Z - Activities related to programming, IT consulting, and related activities

73.11.Z - Advertising agency activities

73.12.C - Advertising through mass media

73.20.Z - Market research and public opinion polling

Payer VAT status

Active

Vat list bank account(s)

PL49 2490 0005 0000 4530 0034 4035

PL17 1240 6247 1111 0000 4975 8748

PL18 1240 6074 1111 0010 3478 4474

PL27 1240 1037 1978 0010 8964 2237

PL80 1240 6247 1111 0000 4979 2146

Show more bank accounts from VAT list (2)

Company authorities

representation authorityTHE COMPANY'S MANAGEMENT

supervisory authorityboard of directors

representation type

KAŻDY Z CZŁONKÓW ZARZĄDU SPÓŁKI JEST UPRAWNIONY DO JEJ SAMODZIELNEGO REPREZENTOWANIA

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Gross profit (loss)	2,9	2,9	3,8	30,8
EBITDA	2,9	3,2	3,7	16,5
Short time liabilities	0,9	1	1,1	7,6
Equity capital	6,8	9,2	12,2	33,5
Operating profit (EBIT)	2,9	2,9	3,6	26
Assets	7,7	10,1	13,3	31
Net profit (loss)	2,3	2,3	3,1	31
Cash	5,6	5,4	10,8	97,8
Net income from sale	8,9	10,2	11,7	14,2
Liabilities and provisions for liabilities	0,9	1	1,1	7,6
Working assets	7,6	9,9	13,1	32
Depreciation	0	0,3	0	-86,6
	%	%	%	p.p.
Profitability of capital	33,8	25,6	25,1	-0,5
Equity capital to total assets	88,2	90,2	92	1,8
Gross profit margin	32,2	28,3	32,4	4,1
EBITDA Margin	32,7	30,8	31,4	0,6
	Days	Days	Days	Days
Short term commitment turnover cycle	37	35	33	-2

Current financial liquidity indicator	8.350502967834473	10.036355018615723	12.316472053527832	2,3
Net dept to EBITDA	-1.9227547645568848	-1.7266952991485596	-2.9300224781036377	-1,2